The clinical importance of our findings is highlighted by the association of EAT miR-92a-3p levels with a lower risk of major adverse cardiovascular events (MACE), as well as postoperative atrial fibrillation, and the positive association of MACE risk with WNT5A expression in patients with advanced atherosclerosis. The gene discussed is WNT5A; the disease is atherosclerosis.